• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸腺五肽的制剂前研究:分析方法的开发、理化性质、动力学降解研究及制剂学展望。

Preformulation studies of thymopentin: analytical method development, physicochemical properties, kinetic degradation investigations and formulation perspective.

机构信息

School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.

Department of Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.

出版信息

Drug Dev Ind Pharm. 2021 Oct;47(10):1680-1692. doi: 10.1080/03639045.2022.2048666. Epub 2022 Mar 15.

DOI:10.1080/03639045.2022.2048666
PMID:35234086
Abstract

Thymopentin (TP5) is a synthetic pentapeptide with immunomodulatory properties. Given the previously described poor absorption of TP5, preformulation data is required to support effective formulation development. In this manuscript, an analytical method of TP5 was developed and validated to determine the aqueous solubility, stability, and Log P of TP5. Thermal properties were investigated, and chemical, physical and enzymatic degradation were evaluated. TP5 was informed to load in a microemulsion (ME) system according to the preformulation parameters and characterized for rheological behavior, droplet size, morphology and drug release. TP5 displayed high aqueous solubility (294.3 mg/mL), low Log P (-4.2) and 2% water content with a melting temperature of 193 °C. TP5 degraded rapidly in alkaline conditions, at elevated temperature, in oxidizing agents, and with UV exposure, however TP5 had a longer half-life in acidic conditions. The fastest enzymatic degradation was with Trypsin (half-life 6.3 h) compared with other digestive enzymes. The different degradation pathways followed first-order kinetics, and half-lives were obtained from the kinetic studies. The TP5 loaded ME exhibited a droplet size of 143 ± 35 nm with a Higuchi-model fitted sustained release profile for 24 h. These data justify and support the design of formulations to stabilize and enhance the absorption of TP5, with a ME formulation demonstrated.

摘要

胸腺五肽(TP5)是一种具有免疫调节特性的合成五肽。鉴于之前描述的 TP5 吸收不良,需要进行预配方研究以支持有效的配方开发。在本文中,开发并验证了一种用于测定 TP5 的水溶解度、稳定性和 Log P 的分析方法。研究了热特性,并评估了化学、物理和酶降解。根据预配方参数,TP5 被指示载入微乳液(ME)系统,并对其流变行为、粒径、形态和药物释放进行了表征。TP5 表现出高水溶性(294.3mg/mL)、低 Log P(-4.2)和 2%含水量,熔点为 193°C。TP5 在碱性条件下、高温下、在氧化剂存在下以及在紫外线照射下迅速降解,但在酸性条件下具有更长的半衰期。与其他消化酶相比,胰蛋白酶(半衰期 6.3h)对 TP5 的降解最快。不同的降解途径遵循一级动力学,半衰期通过动力学研究获得。负载 TP5 的 ME 表现出 143±35nm 的粒径,并具有符合 Higuchi 模型的 24h 持续释放特征。这些数据证明并支持了设计制剂以稳定和增强 TP5 吸收的合理性,其中展示了 ME 制剂的效果。

相似文献

1
Preformulation studies of thymopentin: analytical method development, physicochemical properties, kinetic degradation investigations and formulation perspective.胸腺五肽的制剂前研究:分析方法的开发、理化性质、动力学降解研究及制剂学展望。
Drug Dev Ind Pharm. 2021 Oct;47(10):1680-1692. doi: 10.1080/03639045.2022.2048666. Epub 2022 Mar 15.
2
Exploring ex vivo peptideolysis of thymopentin and lipid-based nanocarriers towards oral formulations.探索胸腺五肽的离体肽酶解作用和基于脂质的纳米载体向口服制剂的发展。
Int J Pharm. 2022 Sep 25;625:122123. doi: 10.1016/j.ijpharm.2022.122123. Epub 2022 Aug 20.
3
Influence of potential inhalation carriers on stability of thymopentin in rat bronchoalveolar lavage fluid.潜在吸入载体对胸腺五肽在大鼠支气管肺泡灌洗液中稳定性的影响。
Drug Deliv. 2014 Sep;21(6):495-500. doi: 10.3109/10717544.2013.878002. Epub 2014 Mar 10.
4
Box-Behnken optimization design and enhanced oral bioavailability of thymopentin-loaded poly (butyl cyanoacrylate) nanoparticles.胸腺五肽负载聚氰基丙烯酸丁酯纳米粒的Box-Behnken优化设计及口服生物利用度提高
Pharmazie. 2011 May;66(5):339-47.
5
Biobased dynamic hydrogels by reversible imine bonding for controlled release of thymopentin.基于可逆亚胺键的生物基动态水凝胶用于控制胸腺五肽的释放。
Mater Sci Eng C Mater Biol Appl. 2021 Aug;127:112210. doi: 10.1016/j.msec.2021.112210. Epub 2021 May 27.
6
Thymopentin-loaded phospholipid-based phase separation gel with long-lasting immunomodulatory effects: in vitro and in vivo studies.载胸腺五肽的磷脂基相分离凝胶具有长效免疫调节作用:体外和体内研究。
Acta Pharmacol Sin. 2019 Apr;40(4):514-521. doi: 10.1038/s41401-018-0085-8. Epub 2018 Jul 12.
7
Preparation and evaluation of poly-butylcyanoacrylate nanoparticles for oral delivery of thymopentin.用于胸腺五肽口服递送的聚氰基丙烯酸丁酯纳米粒的制备与评价
J Pharm Sci. 2008 Jun;97(6):2250-9. doi: 10.1002/jps.21148.
8
Thymopentin nanoparticles engineered with high loading efficiency, improved pharmacokinetic properties, and enhanced immunostimulating effect using soybean phospholipid and PHBHHx polymer.使用大豆磷脂和聚(3-羟基丁酸酯-co-3-羟基己酸酯)(PHBHHx)聚合物制备的具有高负载效率、改善的药代动力学性质和增强的免疫刺激作用的胸腺五肽纳米颗粒。
Mol Pharm. 2014 Oct 6;11(10):3371-7. doi: 10.1021/mp400722r. Epub 2014 Mar 31.
9
Novel thymopentin release systems prepared from bioresorbable PLA-PEG-PLA hydrogels.新型生物可吸收 PLA-PEG-PLA 水凝胶胸腺五肽释放系统。
Int J Pharm. 2010 Feb 15;386(1-2):15-22. doi: 10.1016/j.ijpharm.2009.10.045. Epub 2009 Nov 4.
10
Thymopentin-loaded pH-sensitive chitosan nanoparticles for oral administration: preparation, characterization, and pharmacodynamics.用于口服给药的胸腺五肽负载pH敏感壳聚糖纳米粒:制备、表征及药效学
J Nanosci Nanotechnol. 2006 Sep-Oct;6(9-10):2936-44. doi: 10.1166/jnn.2006.451.

引用本文的文献

1
Enhancing the Oral Bioavailability of Glutathione Using Innovative Analogue Approaches.采用创新类似物方法提高谷胱甘肽的口服生物利用度。
Pharmaceutics. 2025 Mar 18;17(3):385. doi: 10.3390/pharmaceutics17030385.
2
Innovative Solid Lipid Nanoparticle-Enriched Hydrogels for Enhanced Topical Delivery of L-Glutathione: A Novel Approach to Anti-Ageing.用于增强L-谷胱甘肽局部递送的创新型富含固体脂质纳米颗粒的水凝胶:一种抗老化的新方法。
Pharmaceutics. 2024 Dec 24;17(1):4. doi: 10.3390/pharmaceutics17010004.
3
Cellular Uptake and Transport Mechanism Investigations of PEGylated Niosomes for Improving the Oral Delivery of Thymopentin.
用于改善胸腺五肽口服递送的聚乙二醇化脂质体的细胞摄取和转运机制研究
Pharmaceutics. 2024 Mar 14;16(3):397. doi: 10.3390/pharmaceutics16030397.
4
Enhanced Cellular Uptake and Transport of Bovine Lactoferrin Using Pectin- and Chitosan-Modified Solid Lipid Nanoparticles.使用果胶和壳聚糖修饰的固体脂质纳米颗粒增强牛乳铁蛋白的细胞摄取和转运
Pharmaceutics. 2023 Aug 21;15(8):2168. doi: 10.3390/pharmaceutics15082168.